Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 25, Issue 2, Pages 231-243Publisher
IOS PRESS
DOI: 10.3233/JAD-2011-101866
Keywords
Alzheimer's disease; amyloid-beta; amyloid-beta protein precursor; hole board task; memory; motor coordination; rodent; transgenic; water maze
Categories
Funding
- NIH [AG18440, AG022074, AG03197, AG010435]
- NATIONAL INSTITUTE ON AGING [P01AG010435, R37AG018440, P01AG022074, R01AG018440] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Elucidating the age-dependent alterations in transgenic (Tg) mice overexpressing amyloid-beta protein precursor (A beta PP) is important for understanding the pathogenesis of Alzheimer's disease (AD) and designing experimental therapies. Cross-studies have previously characterized some time-dependent behavioral and pathological alterations in A beta PP Tg mice, however, a more comprehensive longitudinal study is needed to fully examine the progressive nature of behavioral deficits in these mice. In order to better understand the age-and gender-dependent progression of behavioral alterations, we performed a longitudinal study wherein Tg mice overexpressing human A beta PP751 with the London (V717I) and Swedish (K670 M/N671L) mutations under the regulatory control of the neuron specific murine (m) Thy-1 promoter (mThy1-hA beta PP751) were behaviorally analyzed at 3 months and then re-tested at 6 and 9 months of age. The results show that there was an age-associated impairment in learning in the water maze task and habituation in the hole-board task. Motor coordination of the mThy1-hA beta PP751 Tg mice was well-preserved throughout the investigated life span however, gender-specific deficits were observed in spontaneous activity and thigmotaxis. Neuropathologically, mThy1-hA beta PP751 Tg mice displayed a progressive increase in the number of A beta plaques and mean plaque size in the cortex and hippocampus from 3 to 6 and from 6 to 9 months of age. Taken together, these results indicate that the mThy1-hA beta PP751 Tg mice model AD from the early onset of the disease through to later stages, allowing them to be utilized at numerous points during the timeline for drug test designs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available